Differential effect of ebselen on compound 48/80- and anti-IgE-induced histamine release from rat peritoneal mast cells

被引:7
作者
Tchoumkeu-Nzouessa, GC
Rebel, G
机构
[1] Ciba Vis Preclin Ophtha Unit Novartis, CH-4002 Basel, Switzerland
[2] Hop Civil IRCAD, CNRS, UPR 9003, Strasbourg, France
关键词
ebselen; N-ethylmaleimide; alkylating reagent; mast cells; histamine; inflammation;
D O I
10.1016/S0006-2952(98)00252-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
2-Phenyl-1, 2-benzisoselenazol-3-(2H)one (ebselen), a nontoxic seleno-organic compound, exhibits anti-inflammatory activity through the inhibition of many enzymes involved in inflammation. In view of the role played by histamine in the pathophysiology of inflammation, we looked at the effect of ebselen on histamine secretion by rat peritoneal mast cells. It inhibited compound 48/80-induced histamine release in a concentration-dependent manner. Half-maximal and maximal (100%) inhibitory response occurred at 5.10(-7)M and 10(-5)M, respectively. In contrast, ebselen was without any effect on histamine release induced immunologically. Prevention of the inhibitory effect of ebselen by GSH suggests that it interacts with critical thiols involved in the compound 48/80 activation pathway. BIOCHEM PHARMACOL 56;11:1525-1528, 1998. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:1525 / 1528
页数:4
相关论文
共 20 条
  • [1] BARNES PJ, 1988, PHARMACOL REV, V40, P49
  • [2] CHARACTERIZATION AND QUANTITATION OF A SELENOL INTERMEDIATE IN THE REACTION OF EBSELEN WITH THIOLS
    COTGREAVE, IA
    MORGENSTERN, R
    ENGMAN, L
    AHOKAS, J
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1992, 84 (01) : 69 - 76
  • [3] EBSELEN PREVENTS INOSITOL (1,4,5)-TRISPHOSPHATE BINDING TO ITS RECEPTOR
    DIMMELER, S
    BRUNE, B
    ULLRICH, V
    [J]. BIOCHEMICAL PHARMACOLOGY, 1991, 42 (05) : 1151 - 1153
  • [4] ENGLBERGER W, 1986, British Journal of Pharmacology, V87, p15P
  • [5] INFLUENCE OF PHOSPHATIDYL SERINE ON RELEASES OF HISTAMINE FROM ISOLATED RAT MAST-CELLS INDUCED BY DIFFERENT AGENTS
    GROSMAN, N
    DIAMANT, B
    [J]. AGENTS AND ACTIONS, 1975, 5 (04): : 296 - 301
  • [6] EFFECTS OF PH, REDUCING AND ALKYLATING REAGENTS ON THE BINDING AND CA-2+ RELEASE ACTIVITIES OF INOSITOL 1,4,5-TRIPHOSPHATE IN THE BOVINE ADRENAL-CORTEX
    GUILLEMETTE, G
    SEGUI, JA
    [J]. MOLECULAR ENDOCRINOLOGY, 1988, 2 (12) : 1249 - 1255
  • [7] PREFERENTIAL INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE BY EBSELEN
    HATTORI, R
    INOUE, R
    SASE, K
    EIZAWA, H
    KOSUGA, K
    AOYAMA, T
    MASAYASU, H
    KAWAI, C
    SASAYAMA, S
    YUI, Y
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 267 (02): : R1 - R2
  • [8] ISHIZAKA T, 1982, FED PROC, V41, P17
  • [9] EBSELEN REDUCES THE FORMATION OF LTB4 IN HUMAN AND PORCINE LEUKOCYTES BY ISOMERIZATION TO ITS 5S,12R-6-TRANS-ISOMER
    KUHL, P
    BORBE, HO
    FISCHER, H
    ROMER, A
    SAFAYHI, H
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1986, 31 (06) : 1029 - 1048
  • [10] STRUCTURAL REQUIREMENTS FOR NEUROPEPTIDE-Y IN MAST-CELL AND G-PROTEIN ACTIVATION
    MOUSLI, M
    TRIFILIEFF, A
    PELTON, JT
    GIES, JP
    LANDRY, Y
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 289 (01): : 125 - 133